O7 - Improving management of gonorrhea in times of increasing antimicrobial resistance

Moderator(s)

• HH

  Hunter Handsfeld
• 

  Katherine Hsu, MD, MPH (she/her/hers)

  Medical Director, Division of STD Prevention & HIV/AIDS Surveillance
  MDPH
  Jamaica Plain, Massachusetts, United States

Presentations:

• 10:00 – 10:15 CST

  Within-person differences of N. gonorrhoeae antimicrobial resistance patterns between anatomical locations
  

  Primary Presenter: Maartje Visser, MSc (she/her/hers) – National Institute for Public Health and the Environment (RIVM)
• 10:15 – 10:30 CST

  Routine Pharyngeal Gonorrhea Test-of-Cure: Does It Detect Treatment Failures?
  

  Primary Presenter: Laura A. S Quilter, MD, MPH (she/her/hers) – U.S. Centers for Disease Control and Prevention
• 10:30 – 10:45 CST

  The impact of near-to-patient testing of sexually transmitted infections on clinical practice and antimicrobial stewardship: the NEPTUNE study
  

  Primary Presenter: Lenka A. Vodstrcil, PhD (she/her/hers) – Monash University and Melbourne Sexual Health Centre
• 10:45 – 11:00 CST

  Neisseria gonorrhoeae diagnostic escape from a gyrA-based test for ciprofloxacin susceptibility and the impact on zoliflodacin resistance
  

  Primary Presenter: Daniel H. Rubin – Harvard School of Public Health
• 11:00 – 11:15 CST

  Perceived benefits and implementation considerations for a novel lateral flow assay for the point-of-care detection of Neisseria gonorrhoeae in public healthcare facilities in South Africa
  

  Primary Presenter: Lindsey A. de Vos, MSc (she/her/hers) – Foundation for Professional Development
• 11:15 – 11:30 CST

  Resistance-minimizing strategies for introducing a novel antibiotic for gonorrhea treatment: a mathematical modeling study
  

  Primary Presenter: Yonatan H. Grad, MD, PhD – Harvard T.H. Chan School of Public Health

  Co-Author: Emily Reichert – Harvard T.H. Chan School of Public Health